Search

MSK now offers interventional radiology consultations as well as many procedures at three of its outpatient locations.

… Thursday, January 12, 2017 Summary Memorial Sloan Kettering is making interventional radiology consultations as well as many procedures available to patients receiving treatment at our locations in Westchester , New York; Commack, Long Island; and Monmouth , New Jersey. Highlights Interventional radiology

An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.

… Monday, April 8, 2024 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that  Jeffrey A. Drebin, MD, PhD , has been named President-Elect of the  American Surgical Association (ASA) for 2024. An internationally recognized surgeon-scientist and the Chair of MSK’s Department of Surgery,

Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, including lung and endometrial cancers.

… Monday, October 28, 2024 Obesity or being overweight can  increase your risk of developing cancer . It can lead to chronic inflammation and hormonal changes, which can damage DNA and cause uncontrolled cell growth.  Now new research at Memorial Sloan Kettering Cancer Center (MSK) suggests obesity may

In a first-of-its-kind collaboration, MSK has joined forces with the Chinese Thoracic Oncology Group in an effort to establish a program of clinical trials that are open to patients from both the United States and China.

… Friday, April 19, 2019 In a first-of-its-kind collaboration, Memorial Sloan Kettering has joined forces with the Chinese Thoracic Oncology Group (CTONG) — an alliance of more than 20 premier academic cancer centers in China — in an effort to establish a program of clinical trials that are open to patients

在史上首次该类型合作中，MSK 与中国胸部肿瘤研究协作组将携手共进，共同打造一个对来自美国和中国的患者都开放的临床试验项目。

… Friday, April 19, 2019 中国胸部肿瘤研究协作组 (CTONG) 是由 20 多个中国顶尖学术癌症中心组成的联盟。Memorial Sloan Kettering 首次与 CTONG 合作，努力促成一项对中美两国患者开放的临床试验项目。 该举措将重点关注 肺癌 精准治疗的临床试验。在中美两国，肺癌都是癌症致死的头号杀手。 此次合作于去年 12 月正式启动，旨在为中美两国的多中心 临床试验 奠定学术基础，最终目标是提高临床试验参与率，推动有效的新疗法尽快获批。 合作期间还实施了其他显著措施，包括远程医疗和教育举措，旨在改善两国患者的护理状况，并努力推动行业参与。 为获得该领域的指导

While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines.

… Thursday, April 23, 2020 While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines. Memorial Sloan Kettering Cancer Center (MSK) is encouraging our healthcare heroes to take a moment to recharge during this challenging time.

MSK molecular geneticist and data scientist Elli Papaemmanuil is leading an initiative to identify the genomic changes that drive pediatric tumors.

… Monday, September 30, 2019 Summary About half of pediatric tumors have a significant mutation that can be identified with standard clinical tests. MSK researchers are looking for a better way to detect mutations in the rest. MSK-IMPACT ™ detects changes in more than 400 cancer-associated genes. The test

New research from MSK investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies.

… Friday, May 24, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies. Anti-ceramide immunotherapy promising against

American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering Cancer Center.

… Thursday, July 10, 2008 Blake Aims to Raise $1 Million for the Fund in Its Inaugural American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering

Brain cancer is deadly because it’s so difficult to study. Scientist Luis Parada has developed an innovative model to analyze how brain tumors form and respond to treatment.

… Friday, January 1, 2021 Finding a treatment for brain tumors like glioblastoma (GBM) has been a heartbreaking challenge. The five-year survival rate is less than 10% for patients 45 and older. Because these tumors are relatively rare and located in such a sensitive and well-sheltered part of the body